TY - JOUR
T1 - P300 serine 89
T2 - A critical signaling integrator and its effects on intestinal homeostasis and repair
AU - Lai, Keane K.Y.
AU - Hu, Xiaohui
AU - Chosa, Keisuke
AU - Nguyen, Cu
AU - Lin, David P.
AU - Lai, Keith K.
AU - Kato, Nobuo
AU - Higuchi, Yusuke
AU - Highlander, Sarah K.
AU - Melendez, Elizabeth
AU - Eriguchi, Yoshihiro
AU - Fueger, Patrick T.
AU - Ouellette, Andre J.
AU - Chimge, Nyam Osor
AU - Ono, Masaya
AU - Kahn, Michael
N1 - Funding Information:
Funding: K.K.Y.L. has been supported by NIH K08AA025112. M.K. has been supported by City of Hope Comprehensive Cancer Center Support Grant NIH P30CA033572, NIH R01CA166161, R21NS074392, R21AI105057, and R01HL112638, and the Rotary Coins for Alzheimer’s Research Trust (CART).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3/2
Y1 - 2021/3/2
N2 - Differential usage of Kat3 coactivators, CBP and p300, by β-catenin is a fundamental regulatory mechanism in stem cell maintenance and initiation of differentiation and repair. Based upon our earlier pharmacologic studies, p300 serine 89 (S89) is critical for controlling differential coactivator usage by β-catenin via post-translational phosphorylation in stem/progenitor populations, and appears to be a target for a number of kinase cascades. To further investigate mechanisms of signal integration effected by this domain, we generated p300 S89A knock-in mice. We show that S89A mice are extremely sensitive to intestinal insult resulting in colitis, which is known to significantly increase the risk of developing colorectal cancer. We demonstrate cell intrinsic differences, and microbiome compositional differences and differential immune responses, in intestine of S89A versus wild type mice. Genomic and proteomic analyses reveal pathway differences, including lipid metabolism, oxidative stress response, mitochondrial function and oxidative phosphorylation. The diverse effects on fundamental processes including epithelial differentiation, metabolism, immune response and microbiome colonization, all brought about by a single amino acid modification S89A, highlights the critical role of this region in p300 as a signaling nexus and the rationale for conservation of this residue and surrounding region for hundreds of million years of vertebrate evolution.
AB - Differential usage of Kat3 coactivators, CBP and p300, by β-catenin is a fundamental regulatory mechanism in stem cell maintenance and initiation of differentiation and repair. Based upon our earlier pharmacologic studies, p300 serine 89 (S89) is critical for controlling differential coactivator usage by β-catenin via post-translational phosphorylation in stem/progenitor populations, and appears to be a target for a number of kinase cascades. To further investigate mechanisms of signal integration effected by this domain, we generated p300 S89A knock-in mice. We show that S89A mice are extremely sensitive to intestinal insult resulting in colitis, which is known to significantly increase the risk of developing colorectal cancer. We demonstrate cell intrinsic differences, and microbiome compositional differences and differential immune responses, in intestine of S89A versus wild type mice. Genomic and proteomic analyses reveal pathway differences, including lipid metabolism, oxidative stress response, mitochondrial function and oxidative phosphorylation. The diverse effects on fundamental processes including epithelial differentiation, metabolism, immune response and microbiome colonization, all brought about by a single amino acid modification S89A, highlights the critical role of this region in p300 as a signaling nexus and the rationale for conservation of this residue and surrounding region for hundreds of million years of vertebrate evolution.
UR - http://www.scopus.com/inward/record.url?scp=85102356358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102356358&partnerID=8YFLogxK
U2 - 10.3390/cancers13061288
DO - 10.3390/cancers13061288
M3 - Article
AN - SCOPUS:85102356358
SN - 2072-6694
VL - 13
SP - 1
EP - 22
JO - Cancers
JF - Cancers
IS - 6
M1 - 1288
ER -